GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amarin Corporation Plc (AMRN) [hlAlert]

Rating:
Mkt Perform
AMRN

Amarin Corporation Plc (AMRN) rated Mkt Perform with price target $2 by FBR Capital

Posted on: Wednesday,  Oct 30, 2013  8:25 AM ET by FBR Capital

Amarin Corporation Plc (NASDAQ: AMRN)
rated Mkt Perform with price target $2 by FBR Capital.

Amarin Corporation plc (Amarin) is a late-stage biopharmaceutical company with a focus on cardiovascular disease. Amarin has a range of clinical and preclinical stage compounds to treat central nervous system (CNS) disorders, including Huntington?s disease, myasthenia gravis and Parkinson?s disease. Its cardiovascular programs and non-core CNS programs include AMR101, EN101, Sublingual Apomorphine and AMR 103. The Company's subsidiaries include Amarin Neuroscience Limited, Amarin Pharmaceuticals Ireland Limited, Amarin Pharma Inc, Amarin Finance Limited and Ester Neurosciences Limited.

FBR Capital uses a highly disciplined analysis focused on intrinsic value, which we developed to critically examine the capital structure of the companies we cover, as well as their competitive positions and the growth opportunities within their industries. We apply this discipline – which helps us assess how effectively a company’s managers deploy the capital entrusted to them – not only in our published research but also when making investing and underwriting judgments.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2013 8:25 AM Hold
None
1.91 2.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy